

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, classical pathway (GO:0006958) | 7.46534846 |
| 2 | gonadal mesoderm development (GO:0007506) | 6.32927054 |
| 3 | complement activation (GO:0006956) | 6.08000133 |
| 4 | positive regulation of respiratory burst (GO:0060267) | 5.51902099 |
| 5 | immunoglobulin mediated immune response (GO:0016064) | 5.37824771 |
| 6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.20763869 |
| 7 | antibacterial humoral response (GO:0019731) | 4.96317924 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.83945536 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.81141912 |
| 10 | antimicrobial humoral response (GO:0019730) | 4.78620765 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.64450262 |
| 12 | regulation of cellular extravasation (GO:0002691) | 4.53750364 |
| 13 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.52409474 |
| 14 | humoral immune response (GO:0006959) | 4.46953882 |
| 15 | protein activation cascade (GO:0072376) | 4.44598006 |
| 16 | regulation of antigen processing and presentation (GO:0002577) | 4.30946553 |
| 17 | eosinophil chemotaxis (GO:0048245) | 4.29578041 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 4.28415785 |
| 19 | B cell mediated immunity (GO:0019724) | 4.17389351 |
| 20 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.15083301 |
| 21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.11956203 |
| 22 | regulation of protein glycosylation (GO:0060049) | 4.11509039 |
| 23 | peptide catabolic process (GO:0043171) | 4.06968783 |
| 24 | regulation of respiratory burst (GO:0060263) | 4.01869190 |
| 25 | glomerular filtration (GO:0003094) | 3.94139807 |
| 26 | eosinophil migration (GO:0072677) | 3.87535873 |
| 27 | response to interferon-beta (GO:0035456) | 3.72285128 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71183574 |
| 29 | regulation of hypersensitivity (GO:0002883) | 3.65474091 |
| 30 | positive regulation of pseudopodium assembly (GO:0031274) | 3.63143775 |
| 31 | GDP-mannose metabolic process (GO:0019673) | 3.54669100 |
| 32 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.48573424 |
| 33 | cellular response to interferon-gamma (GO:0071346) | 3.46298993 |
| 34 | renal filtration (GO:0097205) | 3.42564100 |
| 35 | response to interferon-gamma (GO:0034341) | 3.37625004 |
| 36 | regulation of guanylate cyclase activity (GO:0031282) | 3.28184657 |
| 37 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.27419941 |
| 38 | regulation of pseudopodium assembly (GO:0031272) | 3.23582508 |
| 39 | detection of bacterium (GO:0016045) | 3.18414989 |
| 40 | cellular response to type I interferon (GO:0071357) | 3.17697396 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.17697396 |
| 42 | response to type I interferon (GO:0034340) | 3.16379234 |
| 43 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.11443812 |
| 44 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.09149929 |
| 45 | cellular response to arsenic-containing substance (GO:0071243) | 3.09076139 |
| 46 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.08189501 |
| 47 | detection of other organism (GO:0098543) | 3.06326415 |
| 48 | NADH metabolic process (GO:0006734) | 3.06256039 |
| 49 | angiotensin maturation (GO:0002003) | 3.04303385 |
| 50 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.03662941 |
| 51 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.03662941 |
| 52 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.03662941 |
| 53 | T cell costimulation (GO:0031295) | 3.02784870 |
| 54 | production of molecular mediator of immune response (GO:0002440) | 3.00758834 |
| 55 | lymphocyte costimulation (GO:0031294) | 2.99279549 |
| 56 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.98696559 |
| 57 | positive regulation of neutrophil migration (GO:1902624) | 2.98696559 |
| 58 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.95979986 |
| 59 | positive regulation of type 2 immune response (GO:0002830) | 2.93881127 |
| 60 | retina homeostasis (GO:0001895) | 2.93102445 |
| 61 | positive regulation of T cell migration (GO:2000406) | 2.84632534 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 2.83675615 |
| 63 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.83402559 |
| 64 | signal peptide processing (GO:0006465) | 2.76770892 |
| 65 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.74117374 |
| 66 | positive regulation of lymphocyte migration (GO:2000403) | 2.74054234 |
| 67 | regulation of macrophage chemotaxis (GO:0010758) | 2.73970757 |
| 68 | glycolipid catabolic process (GO:0019377) | 2.71526734 |
| 69 | one-carbon compound transport (GO:0019755) | 2.70473280 |
| 70 | leukotriene biosynthetic process (GO:0019370) | 2.70428811 |
| 71 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.68968979 |
| 72 | regulation of T cell migration (GO:2000404) | 2.68169919 |
| 73 | negative regulation of leukocyte migration (GO:0002686) | 2.67894467 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 2.67336601 |
| 75 | regulation of monocyte chemotaxis (GO:0090025) | 2.65475132 |
| 76 | negative regulation of complement activation (GO:0045916) | 2.64463684 |
| 77 | dendritic cell chemotaxis (GO:0002407) | 2.61639686 |
| 78 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.59851652 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59384752 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58617649 |
| 81 | detection of external biotic stimulus (GO:0098581) | 2.55079154 |
| 82 | defense response to fungus (GO:0050832) | 2.54954932 |
| 83 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.54800399 |
| 84 | response to interferon-alpha (GO:0035455) | 2.54418046 |
| 85 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.53415925 |
| 86 | regulation of glycoprotein biosynthetic process (GO:0010559) | 2.53404747 |
| 87 | sodium ion homeostasis (GO:0055078) | 2.53015319 |
| 88 | mature B cell differentiation involved in immune response (GO:0002313) | 2.52175507 |
| 89 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.51606666 |
| 90 | oligosaccharide biosynthetic process (GO:0009312) | 2.51316082 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 2.51194980 |
| 92 | negative regulation of viral entry into host cell (GO:0046597) | 2.51162959 |
| 93 | glutathione biosynthetic process (GO:0006750) | 2.50713120 |
| 94 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.50591639 |
| 95 | disruption of cells of other organism (GO:0044364) | 2.49164388 |
| 96 | killing of cells of other organism (GO:0031640) | 2.49164388 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.48605252 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 2.48036375 |
| 99 | lipoprotein transport (GO:0042953) | 2.46743888 |
| 100 | response to fungus (GO:0009620) | 2.46684284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.14891317 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.03826896 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.79230869 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.98907033 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.18935584 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.86893262 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72063226 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52112194 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.50373253 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42508226 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40723501 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29326062 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.05135567 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03005553 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.02347110 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99217779 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92068514 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90903504 |
| 19 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.88596470 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86402824 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.86185113 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85496758 |
| 23 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.84025065 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80927205 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.72074255 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.68906463 |
| 27 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.62995526 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60901371 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57540298 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56314728 |
| 31 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.55554501 |
| 32 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53920384 |
| 33 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.45606794 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44798174 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38305350 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37525364 |
| 37 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37340203 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35765041 |
| 39 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35713057 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32546543 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29274107 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26955627 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26704666 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22728754 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22652648 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21997649 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19510417 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18275924 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18004044 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.17172958 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17017089 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16830153 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16506025 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16397451 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15745133 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12645579 |
| 57 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12644635 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09937982 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09262278 |
| 60 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09089183 |
| 61 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08964392 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08167264 |
| 63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07963374 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.07951683 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07042078 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06893308 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04942296 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03545835 |
| 69 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03462563 |
| 70 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03352482 |
| 71 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02441742 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01405418 |
| 73 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01220214 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00625702 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00223644 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99947300 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99278062 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98456437 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98294561 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98016866 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97649668 |
| 82 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96378241 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95806103 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94209203 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91663034 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91495231 |
| 87 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89820864 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89708931 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89694784 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87719831 |
| 91 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86613321 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86381433 |
| 93 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85642176 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84850455 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83622056 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 0.83608787 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.83596695 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83566771 |
| 99 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.83122021 |
| 100 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.82507837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.68283361 |
| 2 | MP0005360_urolithiasis | 4.57936675 |
| 3 | MP0005671_abnormal_response_to | 3.05097547 |
| 4 | MP0010155_abnormal_intestine_physiology | 2.97375199 |
| 5 | MP0000685_abnormal_immune_system | 2.90495230 |
| 6 | MP0009840_abnormal_foam_cell | 2.85827858 |
| 7 | MP0001790_abnormal_immune_system | 2.79298094 |
| 8 | MP0005387_immune_system_phenotype | 2.79298094 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.71824456 |
| 10 | MP0009785_altered_susceptibility_to | 2.71519649 |
| 11 | MP0009379_abnormal_foot_pigmentation | 2.66897158 |
| 12 | MP0003303_peritoneal_inflammation | 2.62543671 |
| 13 | MP0003724_increased_susceptibility_to | 2.57190784 |
| 14 | MP0001800_abnormal_humoral_immune | 2.54890376 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.47414803 |
| 16 | MP0005025_abnormal_response_to | 2.40256382 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.23630471 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.23322971 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.19780952 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.18390464 |
| 21 | MP0002723_abnormal_immune_serum | 2.05729387 |
| 22 | MP0003436_decreased_susceptibility_to | 1.98980181 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.98172575 |
| 24 | MP0004782_abnormal_surfactant_physiolog | 1.97072476 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.92837161 |
| 26 | MP0001819_abnormal_immune_cell | 1.92680791 |
| 27 | MP0005166_decreased_susceptibility_to | 1.92286390 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.91829785 |
| 29 | MP0002419_abnormal_innate_immunity | 1.87364749 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.79467897 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.75569082 |
| 32 | MP0009764_decreased_sensitivity_to | 1.75023433 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.74907815 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.74774716 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.67587501 |
| 36 | MP0003866_abnormal_defecation | 1.65914360 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.64886684 |
| 38 | MP0003075_altered_response_to | 1.64789803 |
| 39 | MP0001663_abnormal_digestive_system | 1.62031075 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.57678826 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.56403173 |
| 42 | MP0006082_CNS_inflammation | 1.56264711 |
| 43 | MP0002006_tumorigenesis | 1.51721233 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.51468669 |
| 45 | MP0004043_abnormal_pH_regulation | 1.51395783 |
| 46 | MP0000716_abnormal_immune_system | 1.44922472 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.43779620 |
| 48 | MP0008469_abnormal_protein_level | 1.33499794 |
| 49 | MP0005365_abnormal_bile_salt | 1.31322379 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.31142400 |
| 51 | MP0001756_abnormal_urination | 1.28848270 |
| 52 | MP0001873_stomach_inflammation | 1.27746748 |
| 53 | MP0000343_altered_response_to | 1.27607246 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.26362283 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.23398167 |
| 56 | MP0002136_abnormal_kidney_physiology | 1.19479923 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.18743925 |
| 58 | MP0002398_abnormal_bone_marrow | 1.16734855 |
| 59 | MP0002009_preneoplasia | 1.16270998 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.14665586 |
| 61 | MP0002429_abnormal_blood_cell | 1.12873543 |
| 62 | MP0005381_digestive/alimentary_phenotyp | 1.12843048 |
| 63 | MP0000249_abnormal_blood_vessel | 1.09568780 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.05976116 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.05614723 |
| 66 | MP0000490_abnormal_crypts_of | 1.05458219 |
| 67 | MP0005332_abnormal_amino_acid | 1.04040342 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00342115 |
| 69 | MP0005165_increased_susceptibility_to | 0.99538027 |
| 70 | MP0003448_altered_tumor_morphology | 0.98301572 |
| 71 | MP0002405_respiratory_system_inflammati | 0.97373254 |
| 72 | MP0000477_abnormal_intestine_morphology | 0.93511303 |
| 73 | MP0003045_fibrosis | 0.92961988 |
| 74 | MP0003186_abnormal_redox_activity | 0.92185331 |
| 75 | MP0001905_abnormal_dopamine_level | 0.91745955 |
| 76 | MP0005058_abnormal_lysosome_morphology | 0.90852735 |
| 77 | MP0000689_abnormal_spleen_morphology | 0.90126015 |
| 78 | MP0001664_abnormal_digestion | 0.87883827 |
| 79 | MP0005310_abnormal_salivary_gland | 0.87784399 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.87172845 |
| 81 | MP0002722_abnormal_immune_system | 0.86196999 |
| 82 | MP0000858_altered_metastatic_potential | 0.85793589 |
| 83 | MP0000681_abnormal_thyroid_gland | 0.85227772 |
| 84 | MP0000604_amyloidosis | 0.84965469 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.84113576 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.83718144 |
| 87 | MP0004947_skin_inflammation | 0.83374765 |
| 88 | MP0009763_increased_sensitivity_to | 0.81942028 |
| 89 | MP0008004_abnormal_stomach_pH | 0.80063200 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79828919 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.78793524 |
| 92 | MP0003252_abnormal_bile_duct | 0.77826733 |
| 93 | MP0001764_abnormal_homeostasis | 0.75961169 |
| 94 | MP0002396_abnormal_hematopoietic_system | 0.74682550 |
| 95 | MP0003718_maternal_effect | 0.74635590 |
| 96 | MP0002796_impaired_skin_barrier | 0.73519027 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.70246320 |
| 98 | MP0010329_abnormal_lipoprotein_level | 0.67096375 |
| 99 | MP0000609_abnormal_liver_physiology | 0.66869976 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.65483597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.15729340 |
| 2 | Decreased circulating renin level (HP:0003351) | 5.39460039 |
| 3 | Nuclear cataract (HP:0100018) | 5.27892883 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 5.11336903 |
| 5 | Glomerulonephritis (HP:0000099) | 4.12311217 |
| 6 | Malnutrition (HP:0004395) | 3.92870054 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 3.86118924 |
| 8 | Complement deficiency (HP:0004431) | 3.60676837 |
| 9 | Prostate neoplasm (HP:0100787) | 3.52690362 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.51313895 |
| 11 | Hypokalemic alkalosis (HP:0001949) | 3.50667540 |
| 12 | Alkalosis (HP:0001948) | 3.50550322 |
| 13 | Vasculitis (HP:0002633) | 3.41212824 |
| 14 | Abnormality of complement system (HP:0005339) | 3.35414985 |
| 15 | Abnormality of the prostate (HP:0008775) | 3.33790707 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.27699746 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 3.24509554 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.23928355 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.19248129 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.97011516 |
| 21 | Pustule (HP:0200039) | 2.94635700 |
| 22 | Recurrent bronchitis (HP:0002837) | 2.90372396 |
| 23 | Nephritis (HP:0000123) | 2.88654660 |
| 24 | Zonular cataract (HP:0010920) | 2.87036027 |
| 25 | Meningitis (HP:0001287) | 2.83377042 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82289222 |
| 27 | Obstructive lung disease (HP:0006536) | 2.82289222 |
| 28 | Premature loss of primary teeth (HP:0006323) | 2.82049063 |
| 29 | Emphysema (HP:0002097) | 2.80147109 |
| 30 | Bronchitis (HP:0012387) | 2.79976543 |
| 31 | Hyperaldosteronism (HP:0000859) | 2.74220941 |
| 32 | Chronic diarrhea (HP:0002028) | 2.66958811 |
| 33 | Chronic bronchitis (HP:0004469) | 2.64855303 |
| 34 | Renal salt wasting (HP:0000127) | 2.61577390 |
| 35 | Diaphragmatic weakness (HP:0009113) | 2.59810563 |
| 36 | Nausea (HP:0002018) | 2.53066023 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51219483 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51219483 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51219483 |
| 40 | Posterior subcapsular cataract (HP:0007787) | 2.50659228 |
| 41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48221569 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.43062314 |
| 43 | Abnormality of B cell number (HP:0010975) | 2.39752364 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37279621 |
| 45 | Metabolic alkalosis (HP:0200114) | 2.36518745 |
| 46 | Skin rash (HP:0000988) | 2.33603766 |
| 47 | Recurrent skin infections (HP:0001581) | 2.33100840 |
| 48 | Urticaria (HP:0001025) | 2.32406920 |
| 49 | Recurrent sinusitis (HP:0011108) | 2.31309204 |
| 50 | Hemoptysis (HP:0002105) | 2.31203321 |
| 51 | IgM deficiency (HP:0002850) | 2.29186488 |
| 52 | Restrictive lung disease (HP:0002091) | 2.28716538 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.27652536 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.25028362 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.24620700 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24269796 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24269796 |
| 58 | Orchitis (HP:0100796) | 2.21857931 |
| 59 | Axonal loss (HP:0003447) | 2.20740036 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.16871138 |
| 61 | Lymphopenia (HP:0001888) | 2.15578553 |
| 62 | Myositis (HP:0100614) | 2.11778285 |
| 63 | Recurrent pneumonia (HP:0006532) | 2.04641191 |
| 64 | Hyperkalemia (HP:0002153) | 2.04589721 |
| 65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03423116 |
| 66 | Calf muscle hypertrophy (HP:0008981) | 2.03253376 |
| 67 | Optic neuritis (HP:0100653) | 2.02856318 |
| 68 | Retrobulbar optic neuritis (HP:0100654) | 2.02856318 |
| 69 | Hyponatremia (HP:0002902) | 2.00299616 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.00180322 |
| 71 | Large eyes (HP:0001090) | 1.98425940 |
| 72 | IgG deficiency (HP:0004315) | 1.97084181 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95314369 |
| 74 | Retinal dysplasia (HP:0007973) | 1.92667185 |
| 75 | Hypotension (HP:0002615) | 1.90359306 |
| 76 | Gingivitis (HP:0000230) | 1.90221780 |
| 77 | Abnormality of chloride homeostasis (HP:0011422) | 1.89845326 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 1.87645077 |
| 79 | Hydroxyprolinuria (HP:0003080) | 1.87645077 |
| 80 | Ileus (HP:0002595) | 1.86681846 |
| 81 | Hypokalemia (HP:0002900) | 1.86500637 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86176133 |
| 83 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.85051395 |
| 84 | Ridged nail (HP:0001807) | 1.84158788 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 1.82357095 |
| 86 | Abnormality of the pleura (HP:0002103) | 1.82289333 |
| 87 | Increased cerebral lipofuscin (HP:0011813) | 1.81867540 |
| 88 | B lymphocytopenia (HP:0010976) | 1.81187055 |
| 89 | Porencephaly (HP:0002132) | 1.79009538 |
| 90 | Inflammation of the large intestine (HP:0002037) | 1.78815503 |
| 91 | Petechiae (HP:0000967) | 1.78380765 |
| 92 | Recurrent viral infections (HP:0004429) | 1.77587101 |
| 93 | Bulbar palsy (HP:0001283) | 1.73100434 |
| 94 | Increased IgE level (HP:0003212) | 1.70281222 |
| 95 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.69954206 |
| 96 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.69954206 |
| 97 | Progressive visual loss (HP:0000529) | 1.69775436 |
| 98 | Type I transferrin isoform profile (HP:0003642) | 1.67775911 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 1.67736718 |
| 100 | Cheilitis (HP:0100825) | 1.66674963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 5.25426656 |
| 2 | ERN1 | 4.72994248 |
| 3 | BMPR2 | 3.09792984 |
| 4 | TAOK3 | 2.94927568 |
| 5 | RIPK4 | 2.18059004 |
| 6 | STK16 | 2.17223598 |
| 7 | GRK6 | 2.15919146 |
| 8 | MAP4K1 | 2.14031980 |
| 9 | BLK | 2.10310687 |
| 10 | CSF1R | 1.93744912 |
| 11 | TBK1 | 1.92481878 |
| 12 | MAP3K12 | 1.85841266 |
| 13 | IKBKE | 1.77598145 |
| 14 | TYK2 | 1.72361609 |
| 15 | VRK2 | 1.70826065 |
| 16 | FES | 1.69004412 |
| 17 | ACVR1B | 1.66029066 |
| 18 | IKBKB | 1.65685953 |
| 19 | MST1R | 1.64502129 |
| 20 | KIT | 1.58729752 |
| 21 | ARAF | 1.56155073 |
| 22 | SYK | 1.56036200 |
| 23 | LYN | 1.42377732 |
| 24 | MAPKAPK3 | 1.41139474 |
| 25 | MYLK | 1.39949876 |
| 26 | EIF2AK3 | 1.36453532 |
| 27 | TNK2 | 1.35768862 |
| 28 | MUSK | 1.31387915 |
| 29 | TLK1 | 1.25298183 |
| 30 | MAP3K1 | 1.23727920 |
| 31 | BTK | 1.17168312 |
| 32 | SIK3 | 1.16688672 |
| 33 | ITK | 1.16575212 |
| 34 | TXK | 1.16197891 |
| 35 | JAK3 | 1.15070600 |
| 36 | PRKG2 | 1.14555205 |
| 37 | PDK2 | 1.08793896 |
| 38 | STK24 | 1.02760744 |
| 39 | CCNB1 | 1.02617158 |
| 40 | IRAK3 | 1.00897231 |
| 41 | MAP3K13 | 1.00149195 |
| 42 | MAP3K14 | 0.98090004 |
| 43 | HCK | 0.96456517 |
| 44 | CDK6 | 0.93248809 |
| 45 | NME1 | 0.92221722 |
| 46 | YES1 | 0.89238479 |
| 47 | DYRK1B | 0.85308786 |
| 48 | PRPF4B | 0.85076523 |
| 49 | CSK | 0.84711086 |
| 50 | JAK2 | 0.84037628 |
| 51 | FGFR4 | 0.80987873 |
| 52 | OXSR1 | 0.78942097 |
| 53 | PIK3CG | 0.78353592 |
| 54 | ADRBK2 | 0.78114569 |
| 55 | KDR | 0.77671459 |
| 56 | JAK1 | 0.77628515 |
| 57 | IRAK4 | 0.77006725 |
| 58 | TEC | 0.73745279 |
| 59 | MAP2K2 | 0.72576838 |
| 60 | LCK | 0.72204307 |
| 61 | ZAP70 | 0.71989637 |
| 62 | ERBB3 | 0.70878294 |
| 63 | MAP3K3 | 0.70072322 |
| 64 | PIM2 | 0.68993499 |
| 65 | MAPKAPK5 | 0.66506634 |
| 66 | HIPK2 | 0.64832604 |
| 67 | PIM1 | 0.62196816 |
| 68 | SMG1 | 0.61761663 |
| 69 | PRKCD | 0.61756375 |
| 70 | TRIM28 | 0.59498269 |
| 71 | EPHA2 | 0.57875250 |
| 72 | TESK2 | 0.56885512 |
| 73 | ABL2 | 0.55835872 |
| 74 | EPHA3 | 0.54485588 |
| 75 | GRK5 | 0.54141950 |
| 76 | MAPK7 | 0.53825516 |
| 77 | ABL1 | 0.53784077 |
| 78 | TGFBR2 | 0.53168093 |
| 79 | FLT3 | 0.52004489 |
| 80 | MAP3K2 | 0.51906608 |
| 81 | IGF1R | 0.51641382 |
| 82 | GRK7 | 0.49532636 |
| 83 | MAPK11 | 0.48019795 |
| 84 | PDK1 | 0.48018327 |
| 85 | RPS6KC1 | 0.47138698 |
| 86 | RPS6KL1 | 0.47138698 |
| 87 | RPS6KA6 | 0.46824719 |
| 88 | DAPK3 | 0.46702866 |
| 89 | FGFR3 | 0.46652479 |
| 90 | GRK1 | 0.44660487 |
| 91 | MATK | 0.42787274 |
| 92 | PDPK1 | 0.41659907 |
| 93 | PIK3CA | 0.41485247 |
| 94 | MOS | 0.39131865 |
| 95 | MAPKAPK2 | 0.38683368 |
| 96 | MAP3K10 | 0.37972709 |
| 97 | FER | 0.37882860 |
| 98 | CAMK2D | 0.36753811 |
| 99 | KSR2 | 0.36295496 |
| 100 | EIF2AK2 | 0.36150830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 5.10579092 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.78952168 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.18053284 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.00486382 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.96911720 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.82447853 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.31652783 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.87402051 |
| 9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.75500403 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.32848326 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29410090 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25460484 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95244758 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.82754580 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.57648933 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53120138 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.37108260 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.33572866 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32440032 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.31024722 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24588480 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22167318 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21316191 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18630564 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.17730313 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.17077018 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15782119 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.15671116 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13609390 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08373453 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08184456 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03643135 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.99736595 |
| 34 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98765000 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97339324 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96473337 |
| 37 | Mineral absorption_Homo sapiens_hsa04978 | 0.95270812 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90278060 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84716133 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84531725 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82948918 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77581889 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76477387 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.75769572 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74568791 |
| 46 | Protein export_Homo sapiens_hsa03060 | 0.73173766 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73062164 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.70546675 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68985286 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67863047 |
| 51 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64394817 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64173379 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61766243 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60537795 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58032797 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57970134 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56673177 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54821495 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52534696 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50952470 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50053140 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.49641526 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49044143 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.48856347 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48258327 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45194199 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44189119 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40474909 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39825643 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39689047 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39622348 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39238564 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39152728 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38948069 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38664732 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38336697 |
| 77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35023055 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34790855 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34195543 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33883279 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33216812 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31446508 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.28968491 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28463194 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27709126 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27700779 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27273014 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27195514 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26725993 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25294443 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25292526 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.24320913 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.23140256 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.22049670 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20542158 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.19728491 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.17790583 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17311461 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.14844551 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.14700267 |

